Spectinomycin
Spectinomycin[edit]

Spectinomycin is an antibiotic used primarily in the treatment of gonorrhea, a sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. It is a member of the aminocyclitol class of antibiotics, which are structurally related to aminoglycosides. Unlike aminoglycosides, spectinomycin does not possess the characteristic amino sugars and glycosidic bonds.
Mechanism of Action[edit]
Spectinomycin functions by inhibiting bacterial protein synthesis. It binds to the 30S subunit of the bacterial ribosome, interfering with the translocation step in protein synthesis. This action is bacteriostatic, meaning it inhibits the growth and reproduction of bacteria rather than killing them directly.
Clinical Use[edit]
Spectinomycin is primarily used as an alternative treatment for gonorrhea, especially in cases where the patient is allergic to penicillin or when the causative strain of N. gonorrhoeae is resistant to other antibiotics. It is administered via intramuscular injection.
Pharmacokinetics[edit]
After intramuscular administration, spectinomycin is rapidly absorbed into the bloodstream. It is distributed throughout the body and is excreted primarily by the kidneys. The half-life of spectinomycin is approximately 1 to 2 hours in individuals with normal renal function.
Side Effects[edit]
Common side effects of spectinomycin include pain at the injection site, nausea, dizziness, and fever. Rarely, it may cause allergic reactions, including anaphylaxis.
Resistance[edit]
Resistance to spectinomycin can occur, although it is less common compared to other antibiotics used for gonorrhea. Resistance mechanisms include mutations in the ribosomal RNA that prevent spectinomycin from binding effectively.
History[edit]
Spectinomycin was first isolated in the 1960s from the bacterium Streptomyces spectabilis. It was developed as an antibiotic due to its unique mechanism of action and its effectiveness against certain bacterial infections.
Related Pages[edit]

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian